| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
College of Physicians and Surgeons of Columbia University, Department of Pathology, New York, NY 10032; Departments of
Surgery and
Experimental Medicine and Pathology, Università di Roma "La Sapienza," Rome, Italy;
§
Department of Pathology, University of Oklahoma, Health Sciences Center, Oklahoma City, OK; and
¶
Campus Biomedico, Rome, Italy
Evidence that T cells can down-regulate the immune response by producing or consuming certain cytokines or by lysing APCs or Th cells has been provided in various systems. However, the generation and characterization of suppressor T cell lines have met with limited success. Here we show that xenospecific suppressor T cells can be generated by in vitro stimulation of human T cells with pig APCs. Similar to allospecific suppressors, these xenospecific suppressor T cells carry the CD8+CD28- phenotype and react to MHC class I Ags expressed by the APCs used for priming. TCR spectratyping of T suppressor cells showed oligoclonal usage of TCR-Vß families, indicating that xenostimulation of CD8+CD28- T cells results in Ag-driven selection of a limited Vß repertoire. Xenospecific T suppressor cells prevent the up-regulation of CD154 molecules on the membrane of Th cells, inhibiting their ability to react against the immunizing MHC class II xenoantigens. The mechanism of this suppression, therefore, appears to be blockade of CD154/CD40 interaction required for efficient costimulation of activated T cells.
This article has been cited by other articles:
|
|
 |
|
  J. Zheng, Y. Liu, G. Qin, P.-L. Chan, H. Mao, K.-T. Lam, D. B. Lewis, Y.-L. Lau, and W. Tu Efficient Induction and Expansion of Human Alloantigen-Specific CD8 Regulatory T Cells from Naive Precursors by CD40-Activated B Cells J. Immunol., September 15, 2009; 183(6): 3742 - 3750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Friedline, D. S. Brown, H. Nguyen, H. Kornfeld, J. Lee, Y. Zhang, M. Appleby, S. D. Der, J. Kang, and C. A. Chambers CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance J. Exp. Med., February 16, 2009; 206(2): 421 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Tulunay, S Yavuz, H Direskeneli, and E Eksioglu-Demiralp CD8+CD28-, suppressive T cells in systemic lupus erythematosus Lupus, July 1, 2008; 17(7): 630 - 637. [Abstract] [PDF]
|
|
|
|
 |
|
 S. A. Greenberg Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications Neurology, November 20, 2007; 69(21): 2008 - 2019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ben-David, A. Sharabi, M. Dayan, M. Sela, and E. Mozes The role of CD8+CD28 regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand PNAS, October 30, 2007; 104(44): 17459 - 17464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Baeten, S. Louis, C. Braud, C. Braudeau, C. Ballet, F. Moizant, A. Pallier, M. Giral, S. Brouard, and J.-P. Soulillou Phenotypically and Functionally Distinct CD8+ Lymphocyte Populations in Long-Term Drug-Free Tolerance and Chronic Rejection in Human Kidney Graft Recipients J. Am. Soc. Nephrol., January 1, 2006; 17(1): 294 - 304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Lietz, R. John, E. Burke, M. Schuster, T. B. Rogers, N. Suciu-Foca, D. Mancini, and S. Itescu Immunoglobulin M-to-Immunoglobulin G Anti-Human Leukocyte Antigen Class II Antibody Switching in Cardiac Transplant Recipients Is Associated With an Increased Risk of Cellular Rejection and Coronary Artery Disease Circulation, October 18, 2005; 112(16): 2468 - 2476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Vlad, R. Cortesini, and N. Suciu-Foca License to Heal: Bidirectional Interaction of Antigen-Specific Regulatory T Cells and Tolerogenic APC J. Immunol., May 15, 2005; 174(10): 5907 - 5914. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Manavalan, S. Kim-Schulze, L. Scotto, A. J. Naiyer, G. Vlad, P. C. Colombo, C. Marboe, D. Mancini, R. Cortesini, and N. Suciu-Foca Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity Int. Immunol., August 1, 2004; 16(8): 1055 - 1068. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mocellin, E. Wang, M. Panelli, P. Pilati, and F. M. Marincola DNA Array-Based Gene Profiling in Tumor Immunology Clin. Cancer Res., July 15, 2004; 10(14): 4597 - 4606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ribas, J. A. Wargo, B. Comin-Anduix, S. Sanetti, L. Y. Schumacher, C. McLean, V. B. Dissette, J. A. Glaspy, W. H. McBride, L. H. Butterfield, et al. Enhanced Tumor Responses to Dendritic Cells in the Absence of CD8-Positive Cells J. Immunol., April 15, 2004; 172(8): 4762 - 4769. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ribas, L. H. Butterfield, J. A. Glaspy, and J. S. Economou Current Developments in Cancer Vaccines and Cellular Immunotherapy J. Clin. Oncol., June 15, 2003; 21(12): 2415 - 2432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sato, N. Yamashita, M. Baba, and T. Matsuyama Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells Blood, May 1, 2003; 101(9): 3581 - 3589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. N. Naumov, E. N. Naumova, K. T. Hogan, L. K. Selin, and J. Gorski A Fractal Clonotype Distribution in the CD8+ Memory T Cell Repertoire Could Optimize Potential for Immune Responses J. Immunol., April 15, 2003; 170(8): 3994 - 4001. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Chen, M. S. Ford, K. J. Young, M. I. Cybulsky, and L. Zhang Role of Double-Negative Regulatory T Cells in Long-Term Cardiac Xenograft Survival J. Immunol., February 15, 2003; 170(4): 1846 - 1853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Dengler, D. R. Johnson, and J. S. Pober Human Vascular Endothelial Cells Stimulate a Lower Frequency of Alloreactive CD8+ Pre-CTL and Induce Less Clonal Expansion than Matching B Lymphoblastoid Cells: Development of a Novel Limiting Dilution Analysis Method Based on CFSE Labeling of Lymphocytes J. Immunol., March 15, 2001; 166(6): 3846 - 3854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Wagar, M. A. Cromwell, L. D. Shultz, B. A. Woda, J. L. Sullivan, R. M. Hesselton, and D. L. Greiner Regulation of Human Cell Engraftment and Development of EBV-Related Lymphoproliferative Disorders in Hu-PBL-scid Mice J. Immunol., July 1, 2000; 165(1): 518 - 527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Vukmanovic-Stejic, B. Vyas, P. Gorak-Stolinska, A. Noble, and D. M. Kemeny Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes Blood, January 1, 2000; 95(1): 231 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Li, Z. Liu, S. Jiang, R. Cortesini, S. Lederman, and N. Suciu-Foca T Suppressor Lymphocytes Inhibit NF-{kappa}B-Mediated Transcription of CD86 Gene in APC J. Immunol., December 15, 1999; 163(12): 6386 - 6392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Suzuki, Y. W. Zhou, M. Kato, T. W. Mak, and I. Nakashima Normal Regulatory {alpha}/{beta} T Cells Effectively Eliminate Abnormally Activated T Cells Lacking the Interleukin 2 Receptor {beta} in Vivo J. Exp. Med., December 6, 1999; 190(11): 1561 - 1572. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
